Sommaire – Groupe de l’étude Interphone Cancer du cerveau

L’étude Interphone désigne une série d’études cas-témoins multinationales, dont l’objectif est de déterminer si l’exposition aux radiofréquences produites par les téléphones mobiles est associée à un risque de cancer. Le Centre international de recherche sur le cancer (CIRC) à coordonné cette étude, dans le cadre de laquelle sont également examinés d’autres facteurs de risque environnementaux et endogènes potentiels. Les formes de cancer étudiées sont le neurinome de l’acoustique, le gliome, le méningiome et les tumeurs de la parotide.

L’Australie, le Canada, le Danemark, la Finlande, la France, l’Allemagne, Israël, l’Italie, le Japon, la Nouvelle-Zélande, la Norvège, la Suède et le Royaume-Uni ont participé à cette étude. The principal investigators of the INTERPHONE study  published a paper that provided details of the design and epidemiological methods, as well as a description of the population included in the study (Cardis et al., 2007). The population included 2,765 glioma, 2,425 meningioma, 1,121 acoustic neuroma, 109 malignant parotid gland tumour cases and 7,658 controls. The paper discussed potential recall and participation biases and their impact on the results. Others papers have also been published on (1) the validation of short term recall of mobile phone use for the Interphone study, (2) the effects of recall errors and of selection bias, (3) and the recall bias in the assessment of exposure to mobile phones from a retrospective validation study. A publication on the distribution of RF energy emitted by mobile phones in anatomical structures of the brain was also recently published in 2010.

Results of national studies have been published since 2004 and are summarized below in Tables (a,b,c). The combined analyses of the 13 countries participating in the INTERPHONE study have been finalized and the results are published in the International Journal of Epidemiology.

The Interphone study group is currently working on detailed analyses for future publications such as precise localization of brain tumours using 3-dimensional radiological grid, the health effect of radiofrequency exposure at the exact location of the tumor by using a gradient of radiofrequency. Determinants of mobile phone output power from a software-modified phone (SMP) study is also in preparation. Results from both the prospective and retrospective validation studies and also data obtained from the simulation study of recall and selection bias will help make any adjustment for exposure measurement errors on cancer risk related to mobile phone use.

Pour de plus amples renseignements, visitez le site www.iarc.fr – suivre les liens « Organigramme du CIRC » et « Groupe Rayonnements ».

Les tableaux qui suivent présentent un résumé des projets sur les tumeurs cérébrales, y compris le neurinome de l’acoustique, qui sont menés dans le cadre de l’étude Interphone. (Pour consulter les résultats complets des études sur les tumeurs cérébrales, voir la rubrique « Épidémiologique » dans le menu principal.)

a) Glioma

Nom, site
Cas
(taux de participation %)
Témoins
(taux de participation
%)
Tranche d'âge
RI usage ordinaire
(95% IC)
RI = 10 ans
Autre
Christensen '05 Denmark
252 (71)
485 (64)
20-69
0.71 (0.50-1.01)
1.64 (0.44-6.12) - low grade tumours -6 cases
= 10 yrs - high grade 0.48 (0.19-1.26) - 8 cases
Lonn '05 Sweden
371 (74)
674 (71)
20-69
0.8 (0.6-1.0)
0.9 (0.5-1.5) - 25 cases
Parietal/temporal lobes 0.8 (0.6-1.1)
Schuz '06 Germany
366 (79.6)
732 (62.7)
30-69
0.98 (0.74-1.29)
2.20 (0.94-5.11) -12 cases
Cordless 0.93
Hepworth '06 UK
966 (51)
1716 (45)
18-69
0.94 (0.78-1.13)
0.90 (0.63-1.28) – 66 cases
Ipsilateral 1.24 (1.02-1.52) Contralateral 0.75 (0.61-0.93)
Klaeboe '07 Norway
289 (77)
358 (69)
19-69
0.6 (0.4-0.9)
0.6 (0.4-0.9)
Ipsilateral 1.0 (0.7-1.4)
Lahkola '07 Nordic countries combined
1521 (60)
3301 (50)
18-69
0.78 (0.7-0.9)
0.95 (0.74-1.23)
Ipsilateral ≥ 10 yrs 1.39 (1.01-1.92)
Hours '07 France
96 (60)
96 (74.7)
30-59
1.15 (0.65-2.05)
0
Ipsilateral 1.15 (0.55-2.43)
Takebayashi '08 Japan
83 (59)
196 (53)
30-69
1.22 (0.63–2.37)
0.58 (0.09–3.86)
Ipsilateral
1.24 (0.67–2.29) Contralateral
1.08 (0.57–2.03)


b) Meningioma

Nom, site
Cas
(taux de participation %)
Témoins
(taux de participation
%)
Tranche d'âge
RI usage ordinaire
(95% IC)
RI = 10 ans
Autre
Christensen '05 Denmarke
175 (74)
316 (64)
20-69
0.83 (0.54-1.28)
1.02 (0.32-3.24)
Lonn '05 Swede
273 (85)
674 (71)
20-69
0.7 (0.5-0.9)
0.9 (0.4-1.9)
Schuz '06 Alemagne
381 (88.4)
762 (62.7)
30-69
0.84 (0.62-1.13)
1.09 (0.35-3.37)
Klaeboe '07 Norway
207 (71)
358 (69)
19-69
0.8 (0.5-1.1)
0
Hours '07
145 (78.4)
145 (74.7)
30-59
0.74 (0.43-1.28)
0
Ipsilateral 0.62 (0.32-1.20)

Takebayashi '08 Japan

128 (78)

279 (52)

30-69

0.70 (0.42–1.16)

1.35 (0.31–5.93)

Ipsilateral            1.14 (0.65–2.01) Contralateral        0.65 (0.37–1.13)

Lahkola '08 Nordic countries combined

1209 (74)

3299 (50)

20-69
18-59 (England)

0.76 (0.65-0.89)

0.85 (0.57-1.26)

Ipsilateral ≥ 10 yrs 0.99 (0.57-1.73)


c) Acoustic neuroma

Auteur
No. de cas
RI tout usage
RI>5
RI>10
Commentaire
Christensen 2004
106
0.9
(n=17) 0.86
(n=2) 0.22
Ipsilateral use: OR =0.68
Lonn 2004
148
1.0
(n = 30) (5-9 yrs) 1.1
(n = 14) 1.9 (0.9-4.1)
Ipsilateral use: OR 1.1; for 5-9 yrs 1.1; for = 10 yrs 3.9 (1.6-9.5) Contralateral use: 0.9 for all durations
Schoemaker 2005
678
0.9
0.9
1.1 (0.7-1.8)
Ipsilateral use: OR = 0.9; for >10 years since first use, OR = 1.3; OR for >10 lifetime years of use = 1.8 (1.1-3.1)
Takebayashi 2006
101
0.73
(n=19) 1.09 (0.58-2.06)
(n=1)
Ipsilateral use: OR=0.9
Klaeboe 2007
45
0.5
(= 6 yrs)
(n = 7) 0.5 (0.2-1.5)
0
Ipsilateral use: OR = 0.7
Schlehofer 2007
97
0.67 (0.38-1.19)
(n=8) 0.53 (0.22-1.27)
0

OR for persistent noise exposure = 2.31 (1.15-4.66); for hay fever = 2.20 (1.09-4.45)

Hours '07
109 (80.7)
214 (74.7)
0.92 (0.53-1.59)
0
Ipsilateral 0.62 (0.32-1.20)


d) Tumours of the parotid gland

Author
# of cases
OR any use
OR>5
(95% CI)
OR>10
(95% CI)
Comment

Lonn '06 Sweden & Denmark

199

0.7malignant 0.9 benign 

0.7 malignant n=8)
0.9 benign (n=24)

0.3 malignant (n=1)

1.1 benign (n=5)
Ipsilateral use: OR=1.2  (0.6-2.6)

Sadetzki '08 Israel

460

1.06 malignant 0.85 benign

0.79 malignant  (n=12)
1.04 benign (n=129)

0.45 malignant (n=1)
1.02 benign (n=12)

Ipsilateral use: OR 1.01; 1.34 for 5 yrs; 1.69 for ≥ 10 yrs                           



Autres étude Interphone

Schuz (2006c) a aussi étudié le lien entre l’exposition aux stations de base des téléphones sans fil et le risque de cancer du cerveau, mais n’a observé aucune augmentation du risque.

Le même groupe n’a découvert aucune association significative entre l’exposition professionnelle aux CEM des radiofréquences ou des micro-ondes et les tumeurs du cerveau (Berg, 2006).

Le groupe de l’étude Interphone a aussi mené une étude de validation de l’utilisation du téléphone évaluée par remémoration à court terme (Vrijheid, 2006). Des corrélations de modérées à fortes ont été rapportées entre l’usage estimé de mémoire et l’usage réel déterminé par les opérateurs ou à l’aide de téléphones modifiés par logiciel. Les auteurs ont observé une erreur systématique modérée et une erreur aléatoire appréciable. Cette dernière erreur aurait tendance à diminuer la puissance de l’étude Interphone à détecter une augmentation du risque de tumeurs du cerveau, si un tel risque existe.

Kan and colleagues performed a meta-analysis of 9 Interphone studies published between 2000 and 2006 (Kan et al., 2007). The 9 studies included a total of 5,259 cases of primary brain tumours and 12,074 controls. There was an overall Odds ratio (OR) of 0.90 (95% CI 0.81-0.99) for cell phone use and brain tumour development. The pooled OR for cell phone users of ≥ 10 years (5 studies) was 1.25 (95% CI 1.01-1.54).

Schlehofer et al. (2007) used Interphone data to analyze potential environmental risk factors for acoustic neuroma. While there was no risk for ionizing radiation or for cell phone use, they found increased risks for persistent noise and for hay fever history.



Références:

Berg G, Spallek J, Schuz J, Schlefor B, et al. (2006): Occupational exposure to radio frequency/microwave radiation and the risk of brain tumours: Interphone study group, Germany.
Am J Epidemiol 164:538-548.
Sommaire>

Cardis E, Richardson L, Deltour I, Armstrong B, and 44 others (2007): The INTERPHONE study: design, epidemiological methods, and description of the study population. Eur J Epidemiol DOI 10.1007/s10654-007-9152-z.

Cardis E, Deltour I, Mann S, Moissonnier M, Taki M,Varsier N, Wake K, Wiart J. (2008). Distribution of RF energy emitted by mobile phones in anatomical structures of the brain. Phys. Med. Biol. 53:2771–2783.

Christensen HC, Schuz J, Kosteljanetz M, Skovgard H, et al. (2004): Cellular telephone use and risk of acoustic neuroma. Am J Epidemiol 159:277-283
Sommaire>

Christensen HC, Schuz J, Kosteljanetz M, Skovgaard Poulsen H, et al. (2005): Cellular telephones and risk for brain tumours: A population-based, incident case-control study. Neurology 64:1189-1195.
Sommaire>

Hepworth SJ, Schoemaker MJ, Muir KR, Swerdlow AJ, et al. (2006): Mobile phone use and risk of glioma in adults: case-control study. BMJ (published online 20 January)
Sommaire>

Hartikka H,Heinävaara S,Mäntylä R, Kähärä V, Kurttio P, Auvinen A. Mobile phone use and location of glioma: A case-case analysis Bioelectromagnetics Jan 13, 2009 Ahead of print.

Hours M, Montestrucq L, Arslan M, Bernard M, El Hadjimoussa H, Vrijheid M, Deltour I, Cardis E. (2007): Validation des outils utilizes pour la mesure de la consommation téléphonique mobile dans l’étude INTERPHONE en France. Environnement, Risques & Santé 6(2):101-109

Hours M, Bernard M, Montestrucq L, Arslan M, et al. (2007): Téléphone mobile, risque de tumeurs cérébrales et du nerf vestibulaacoustique: l'étude cas-témojns INTERPHONE en France. (Cell phones and risk of brain and acoustic nerve tumours: the French INTERPHONE case-control study). Revue d'Épidémiologie et de Santé Publique 2007, doi: 10.10.16/j.respe.2007.06.002
Sommaire>

Kan P, Simonsen SE, Lyon JL, Kestle JRW (2007): Cellular phone use and brain tumor: a meta-analysis. J Neurooncol DOI 10.1007/s11060-007-9432-1
Go to summary>

Klaeboe L, Blaasaas KG, Tynes T (2007): Use of mobile phones in Norway and risk of intracranial tumours. Eur J Cancer Prev 16:158-164
Go to summary>

Lahkola A, Auvinen A, Raitanen J, Schoemaker MJ, et al. (2007): Mobile phone use and risk of glioma in 5 North European countries. Int J Cancer 120:1769-1775.
Go to summary>

Lahkola A, Salminen T, Raitanen J, Heinävaara S, Schoemaker M, Christensen HC, Feychting M, Johansen C, Klæboe L, Lönn S, Swerdlow A, Tynes T, Auvinen A. Meningioma and mobile phone use--a collaborative case-control study in five North European countries. Int J Epidemiol. Aug 2, 2008 Ahead of print.

Lonn S, Ahlbom A, Hall P, Feychting M (2004): Mobile phone use and the risk of acoustic neuroma. Epidemiology 15:653-659.
Sommaire>

Lonn S, Ahlbom A, Hall P, Feychting M, et al. (2005): Long-term mobile phone use and brain tumour risk. Amer J Epidemiol 161:526-535.
Sommaire>

Lonn S, Ahlbom A, Christensen HC, Johansen C, et al. Mobile phone use and risk of parotid gland tumor. Am J Epidemiol:2006;164:637-643.
Sommaire>

Sadetzki S, Chetrit A, Jarus-Hakak A, Cardis E, Deutch Y, Duvdevani S, Zultan A, Novikov A, Freedman L, Wolf M.  Cellular Phone Use and Risk of Benign and Malignant Parotid Gland Tumors—A
Nationwide Case-Control Study American Journal of Epidemiology Ahead of print December 6, 2007

Schlehofer B, Schlaefer K, Blettner M, Berg G, et al. (2007): Environmental risk factors for sporadic acoustic neuroma (Interphone Study Group, Germany). Eur J Cancer 43:1741-1747.
Sommaire>

Schoemaker MJ, Swerdlow AJ, Ahlbom A, Auvinen A, et al. (2005): Mobile phone use and risk of acoustic neuroma: results of the Interphone case-control study in five North European countries. British Journal of Cancer 2005;93:842-848.
Sommaire>

Schuz J, Bohler E, Berg G, Schlehofer B, et al. (2006a): Cellular phones, Cordless phones, and the risks of glioma and meningioma (Interphone study group, Germany). Am J Epidemiol 163:512-520.
Sommaire>

Schuz J, Bohler E, Schlehofer B, Berg K, et al. (2006c): Radiofrequency electromagnetic fields emitted from base stations of DECT cordless phones and the risk of glioma and meningioma (Interphone study group, Germany). Radiat Res 166:116-119.
Sommaire>

Takebayashi T, Akiba S, Kikuchi Y, Taki M, et al. Mobile phone use and acoustic neuroma risk in Japan. Occup Environ Med: Published online 15 August 2006.
Sommaire>

Takebayashi T, Varsier N, Kikuchi Y, Wake K, Taki M, Watanabe S, Akiba S, Yamaguchi N. Mobile phone use, exposure to radiofrequency electromagnetic field, and brain tumour: a case-control study. Br J Cancer. 2008 98(3):652-659. Epub ahead of print Feb 5 2008. doi:10.1038/sj.bjc.6604214

Vrijheid M, Cardis E, Armstrong BK, Auvinen A, et al. (2006a): Validation of short term recall of mobile phone use for the Interphone study. Occup Environ Med 63:237-243.

Vrijheid M, Deltour I, Krewski D, Sanchez M, et al. (2006b): The effects of recall errors and of selection bias in epidemiologic studies of mobile phone use and cancer risk. Journal of Exposure Science and Environmental Epidemiology, advance online publication 14 June, 2006.

Vrijheid M, Armstrong BK, Bedard D, Brown J, Deltour E, Iavarone I, Krewski D, Lagorio S, Moore S, Richarson L, Giles G, McBride M, Parent M-E, Siemiatycki J, Cardis E. (2008): Recall bias in the assessment of exposure to mobile phones Journal of Exposure Science and Environmental Epidemiology 1–13.

Vrijheid M, Armstrong BK, Bédard D, Brown J, Deltour I, Iavarone I, Krewski D, Lagorio S, Moore S, Richardson L, Giles GG, McBride M, Parent ME, Siemiatycki J, Cardis E.(2009). Recall bias in the assessment of exposure to mobile phones. J Expo Sci Environ Epidemiol. 19, 369–381.

Vrijheid M, Mann S, Vecchia P, Wiart J, Taki M, Ardoino L, Armstrong BK, Auvinen A, Bédard D, Berg-Beckhoff G, Brown J, Chetrit A, Collatz-Christensen H, Combalot E, Cook A, Deltour I, Feychting M, Giles GG, Hepworth SJ, Hours M, Iavarone I, Johansen C, Krewski D, Kurttio P, Lagorio S, Lönn S, McBride M, Montestruq L, Parslow RC, Sadietzki S, Schüz J, Tynes T, Woodward A, Cardis E.(2009). Determinants of mobile phone output power in a multinational study – implications for exposure assessment. Occup Environ Med. 66(10):664-71.

Vrijheid M, Richardson L, Armstrong BK, Auvinen A, Berg G, Carroll M, Chetrit A, Deltour I, Feychting M, Giles GG, Hours M, Iavarone I, Lagorio S, Lönn S, McBride M, Parent ME, Sadetzki S, Salminen T, Sanchez M, Schlehofer B, Schüz J, Siemiatycki J, Tynes T, Woodward A, Yamaguchi N, Cardis E. (2009). Quantifying the impact of selection bias caused by nonparticipation in a case-control study of mobile phone use. Ann Epidemiol 19(1):33-41.

 



Accueil             Liens              Carte du site               Contacez-Nous
© Centre McLaughlin Centre d'évaluation du risque pour la santé des populations